Acadia Healthcare (NASDAQ:ACHC) Given New $30.00 Price Target at KeyCorp

Acadia Healthcare (NASDAQ:ACHCFree Report) had its price target trimmed by KeyCorp from $35.00 to $30.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has an overweight rating on the stock.

A number of other research firms also recently issued reports on ACHC. Royal Bank Of Canada cut their price target on Acadia Healthcare from $28.00 to $22.00 and set an “outperform” rating for the company in a research note on Wednesday, November 12th. Bank of America lowered Acadia Healthcare from a “buy” rating to a “neutral” rating and dropped their target price for the company from $27.00 to $25.00 in a report on Wednesday, September 10th. Cantor Fitzgerald decreased their price target on Acadia Healthcare from $25.00 to $22.00 and set a “neutral” rating for the company in a report on Friday, November 7th. Mizuho lowered their price target on Acadia Healthcare from $32.00 to $22.00 and set a “neutral” rating for the company in a research report on Wednesday, August 13th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, October 8th. Eight analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $32.36.

Read Our Latest Report on ACHC

Acadia Healthcare Stock Performance

NASDAQ ACHC opened at $15.01 on Tuesday. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. The company has a fifty day simple moving average of $22.41 and a 200 day simple moving average of $22.51. Acadia Healthcare has a 12-month low of $14.94 and a 12-month high of $47.08. The company has a market cap of $1.38 billion, a P/E ratio of 9.94, a PEG ratio of 4.56 and a beta of 0.97.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. The firm had revenue of $851.57 million for the quarter, compared to analyst estimates of $852.43 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The business’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same period last year, the firm earned $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Sell-side analysts predict that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Citigroup Inc. increased its holdings in Acadia Healthcare by 5,144.2% during the first quarter. Citigroup Inc. now owns 2,376,209 shares of the company’s stock worth $72,047,000 after buying an additional 2,330,898 shares during the last quarter. Hawk Ridge Capital Management LP grew its position in shares of Acadia Healthcare by 437.5% during the 1st quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company’s stock valued at $74,988,000 after acquiring an additional 2,013,126 shares during the period. Abrams Bison Investments LLC purchased a new stake in shares of Acadia Healthcare during the 1st quarter worth approximately $55,182,000. Maverick Capital Ltd. raised its holdings in shares of Acadia Healthcare by 116.3% in the 1st quarter. Maverick Capital Ltd. now owns 2,246,923 shares of the company’s stock worth $68,127,000 after purchasing an additional 1,208,296 shares during the period. Finally, Deerfield Management Company L.P. purchased a new position in Acadia Healthcare in the third quarter valued at approximately $29,440,000.

Acadia Healthcare Company Profile

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Recommended Stories

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.